Coronary revascularization after thrombolytic therapy for myocardial infarction: what caseloads could Canadian centres face? (Q34576786)

3 August 2017

title

Coronary revascularization after thrombolytic therapy for myocardial infarction: what caseloads could Canadian centres face? (English)

1 reference

3 August 2017

1 reference

1 reference

myocardial infarction

1 reference

Floras JS

1

1 reference

3 August 2017

Naylor CD

series ordinal

2

1 reference

3 August 2017

Armstrong PW

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 October 1989

1 reference

Canadian Medical Association Journal

3 August 2017

published in

1 reference

3 August 2017

volume

141

1 reference

3 August 2017

issue

8

1 reference

3 August 2017

page(s)

783-790

1 reference

Coronary care unit utilization in Hamilton, Ontario, a city of 375,000 people

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1451321

Thrombolytic therapy: current status (1).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1451321

Reperfusion therapy of acute myocardial infarction

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1451321

Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1451321

Coding of acute myocardial infarction. Clinical and policy implications

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1451321

Coronary angioplasty for acute myocardial infarction

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1451321

Report of the Joint ISFC/WHO Task Force on Coronary Angioplasty. The International Society and Federation of Cardiology and the World Health Organization

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1451321

Late restenosis after emergent coronary angioplasty for acute myocardial infarction: comparison with elective coronary angioplasty

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1451321

A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1451321

Significant reduction in mortality with streptokinase given 7-24 hours after pain onset

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1451321

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1451321

Restoration of flow in acute coronary obstructive syndromes: consequences of different management strategies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1451321

Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarction

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1451321

Guidelines for the use of intravenous thrombolytic agents in acute myocardial infarction. Ontario Medical Association Consensus Group on Thrombolytic Therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1451321

Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1451321

Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator

27 October 2018

1 reference

12 December 2020

Restenosis after successful coronary angioplasty in patients with single-vessel disease

1 reference

12 December 2020

Eligibility for thrombolytic therapy in acute myocardial infarction

1 reference

12 December 2020

Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction

1 reference

12 December 2020

The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial

1 reference

12 December 2020

Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty

1 reference

12 December 2020

Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis

1 reference

12 December 2020

Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator

1 reference

12 December 2020

Candidates for thrombolysis among emergency room patients with acute chest pain. Potential true- and false-positive rates

1 reference

12 December 2020

Identifiers

PMC publication ID

1451321

1 reference

3 August 2017

1 reference